Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 532.20M | $ 240.90M | $ 655.90M | $ 744.10M | $ 899.00M |
Total Assets | $ 15.14B | $ 14.44B | $ 14.44B | $ 14.18B | $ 14.51B |
Total Debt | $ 8.26B | $ 7.98B | $ 8.46B | $ 8.45B | $ 8.95B |
Net Debt | $ 7.73B | $ 7.74B | $ 7.81B | $ 7.71B | $ 8.05B |
Total Liabilities | $ 12.02B | $ 11.48B | $ 11.72B | $ 11.15B | $ 11.68B |
Stockholders Equity | $ 3.12B | $ 2.96B | $ 2.72B | $ 3.03B | $ 2.83B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |